Creative Medical Technology
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 4
- Market Cap
- -
- Introduction
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company, which engages in the provision of medical solutions for unmet immunological, urological, neurological, and orthopedic needs. It develops intellectual property portfolio utilizing stem cells and interrelated technologies for the treatment of erectile dysfunction and female sexual dysfunction. The company was founded on December 3, 1998 and is headquartered in Phoenix, AZ.
AlloStem Cell Therapy Shows 80% Efficacy in One-Year Type 2 Diabetes Trial
• Creative Medical Technology's CELZ-201 demonstrated significant reduction in insulin dependency and stable HbA1c levels in late-stage Type 2 diabetes patients over one year of treatment.
• The pilot study of 20 patients showed no serious adverse effects, validating the safety profile of the universal donor cell therapy using the same infusion procedure as their FDA-cleared Type 1 diabetes trial.
• With 38 million Americans diagnosed with diabetes and 96 million classified as prediabetic, this breakthrough treatment could offer new hope for the 90-95% affected by Type 2 diabetes.
Creative Medical's CELZ-201-DDT Shows Promising Safety Profile in Phase 1/2 Degenerative Disc Disease Trial
• Initial data from the first cohort of 10 participants demonstrates excellent safety profile for CELZ-201-DDT stem cell therapy, with no serious adverse events reported in degenerative disc disease treatment.
• Blinded preliminary results indicate potential therapeutic benefits in alleviating chronic back pain and improving functionality, marking a significant step in stem cell-based treatments.
• Independent Data Safety Monitoring Board has approved progression to the second cohort, with enrollment expected to begin in Q1 2025.
© Copyright 2025. All Rights Reserved by MedPath